ArticleBreast cancer research : BCR2022

Combined Dusp4 and p53 loss with Dbf4 amplification drives tumorigenesis via cell cycle restriction and replication stress escape in breast cancer.

Ann Hanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.